SCHEMBL30877934

SCHEMBL30877934

Cc1ccc(OCCCCc2ccc(CNC(=O)OC(C)(C)C)cc2[N+](=O)[O-])cc1B1OC(C)(C)C(C)(C)O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 2/20 0.38
ALDH1A1 P00352 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
BCHE P06276 1/20 0.37
CNR2 P34972 1/20 0.37
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CA12 O43570 5/20 0.35
CA1 P00915 5/20 0.35
CA2 P00918 5/20 0.35
CA9 Q16790 5/20 0.35
GLS O94925 2/20 0.34
MAPT P10636 2/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPK1 P28482 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30954637 0.81 PRMT5 (0.45) AAK1TDP1PRMT5WDR77SMN1; SMN2
SCHEMBL30954635 0.74 PRMT5 (0.48) AAK1PRMT5WDR77GLS
SCHEMBL24619251 0.70 PRMT5 (0.48) AAK1PRMT5WDR77SMN1; SMN2MAPK1
SCHEMBL29925213 0.70 PRMT5 (0.48) AAK1PRMT5WDR77GLS
SCHEMBL20095411 0.70 PRMT5 (0.48) AAK1PRMT5WDR77GLS
SCHEMBL29924642 0.70 PRMT5 (0.48) AAK1PRMT5WDR77SMN1; SMN2MAPK1
SCHEMBL7403833 0.69 ADRB2 (0.44) ALDH1A1TDP1CA1CA2MAPT
SCHEMBL30421137 0.69 CA12 (0.48) AAK1BCHECNR2PRMT5WDR77
SCHEMBL8650989 0.69 PTPN1 (0.40) ALDH1A1TDP1SMN1; SMN2CA1CA2
SCHEMBL31591670 0.68 BCHE (0.48) AAK1ALDH1A1TDP1BCHECNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4610262-A1 MACROCYCLIC COMPOUND AS CDK9 INHIBITOR AND USE THEREOF Artivila Biopharma (CN) 2025-09-03 EP disclosed
WO-2024088189-A1 MACROCYCLIC COMPOUND AS CDK9 INHIBITOR AND USE THEREOF 科辉智药生物科技(无锡)有限公司 2024-05-02 WO disclosed